Lexicon Pharmaceuticals, Inc. LXRX

US Pharmaceuticals

$1.95 ▲ +7.14% (+$0.13)

⬆️ Above Yest. High

Open $1.82

Prev Close $1.82

Day Range $1.80 – $1.97

52W Range $1.10 – $2.68

Market Cap $810.33M

Beta 1.05

EPS (TTM) $-0.15

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-04-07
Shares Out.	444,960,000
Website	lexpharma.com/ ↗
Phone	18009279800
Employees	81
Revenue	$11.3M
Gross Profit	$11.2M
Net Income	-$14.0M
Free Cash Flow	-$49.2M
Total Assets	$242.0M
Total Liabilities	$78.2M
Equity	$163.8M

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Lexicon Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol LXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.